Selected research
Industry Research
Artesunate Medicines Industry Research Report 2026
Market perspective
The global Artesunate Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Artesunate Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Artesunate Medicines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Artesunate Medicines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Artesunate Medicines include Shin Poong, Sanofi Aventis, MCW Healthcare, Ipca Laboratories, Fosun Pharma (Guilin), Cipla, Ajanta Pharma and Acino, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Artesunate Medicines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Artesunate Medicines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artesunate Medicines Market by Company
Shin Poong
Sanofi Aventis
MCW Healthcare
Ipca Laboratories
Fosun Pharma (Guilin)
Cipla
Ajanta Pharma
Acino
Artesunate Medicines Segment by Type
Monoaromatic Artesunate
Compound Artesunate
Artesunate Medicines Segment by Application
Hospital
Clinic
Other
Artesunate Medicines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artesunate Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artesunate Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artesunate Medicines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Artesunate Medicines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Monoaromatic Artesunate
- Compound Artesunate
Applications
- Hospital
- Clinic
- Other
Companies covered
- Shin Poong
- Sanofi Aventis
- MCW Healthcare
- Ipca Laboratories
- Fosun Pharma (Guilin)
- Cipla
- Ajanta Pharma
- Acino
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Artesunate Medicines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Monoaromatic Artesunate
- 2.2.3 Compound Artesunate
- 2.3 Artesunate Medicines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Artesunate Medicines Breakdown Data by Type
- 3.1 Global Artesunate Medicines Historic Market Size by Type (2021-2026)
- 3.2 Global Artesunate Medicines Forecasted Market Size by Type (2027-2032)
4 Artesunate Medicines Breakdown Data by Application
- 4.1 Global Artesunate Medicines Historic Market Size by Application (2021-2026)
- 4.2 Global Artesunate Medicines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Artesunate Medicines Market Perspective (2021-2032)
- 5.2 Global Artesunate Medicines Growth Trends by Region
- 5.2.1 Global Artesunate Medicines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Artesunate Medicines Historic Market Size by Region (2021-2026)
- 5.2.3 Artesunate Medicines Forecasted Market Size by Region (2027-2032)
- 5.3 Artesunate Medicines Market Dynamics
- 5.3.1 Artesunate Medicines Industry Trends
- 5.3.2 Artesunate Medicines Market Drivers
- 5.3.3 Artesunate Medicines Market Challenges
- 5.3.4 Artesunate Medicines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Artesunate Medicines Players by Revenue
- 6.1.1 Global Top Artesunate Medicines Players by Revenue (2021-2026)
- 6.1.2 Global Artesunate Medicines Revenue Market Share by Players (2021-2026)
- 6.2 Global Artesunate Medicines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Artesunate Medicines Head Office and Area Served
- 6.4 Global Artesunate Medicines Players, Product Type & Application
- 6.5 Global Artesunate Medicines Manufacturers Established Date
- 6.6 Global Artesunate Medicines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Artesunate Medicines Market Size (2021-2032)
- 7.2 North America Artesunate Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Artesunate Medicines Market Size by Country (2021-2026)
- 7.4 North America Artesunate Medicines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Artesunate Medicines Market Size (2021-2032)
- 8.2 Europe Artesunate Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Artesunate Medicines Market Size by Country (2021-2026)
- 8.4 Europe Artesunate Medicines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Artesunate Medicines Market Size (2021-2032)
- 9.2 Asia-Pacific Artesunate Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Artesunate Medicines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Artesunate Medicines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Artesunate Medicines Market Size (2021-2032)
- 10.2 South America Artesunate Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Artesunate Medicines Market Size by Country (2021-2026)
- 10.4 South America Artesunate Medicines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Artesunate Medicines Market Size (2021-2032)
- 11.2 Middle East & Africa Artesunate Medicines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Artesunate Medicines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Artesunate Medicines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Shin Poong
- 12.1.1 Shin Poong Company Information
- 12.1.2 Shin Poong Business Overview
- 12.1.3 Shin Poong Revenue in Artesunate Medicines Business (2021-2026)
- 12.1.4 Shin Poong Artesunate Medicines Product Portfolio
- 12.1.5 Shin Poong Recent Developments
- 12.2 Sanofi Aventis
- 12.2.1 Sanofi Aventis Company Information
- 12.2.2 Sanofi Aventis Business Overview
- 12.2.3 Sanofi Aventis Revenue in Artesunate Medicines Business (2021-2026)
- 12.2.4 Sanofi Aventis Artesunate Medicines Product Portfolio
- 12.2.5 Sanofi Aventis Recent Developments
- 12.3 MCW Healthcare
- 12.3.1 MCW Healthcare Company Information
- 12.3.2 MCW Healthcare Business Overview
- 12.3.3 MCW Healthcare Revenue in Artesunate Medicines Business (2021-2026)
- 12.3.4 MCW Healthcare Artesunate Medicines Product Portfolio
- 12.3.5 MCW Healthcare Recent Developments
- 12.4 Ipca Laboratories
- 12.4.1 Ipca Laboratories Company Information
- 12.4.2 Ipca Laboratories Business Overview
- 12.4.3 Ipca Laboratories Revenue in Artesunate Medicines Business (2021-2026)
- 12.4.4 Ipca Laboratories Artesunate Medicines Product Portfolio
- 12.4.5 Ipca Laboratories Recent Developments
- 12.5 Fosun Pharma (Guilin)
- 12.5.1 Fosun Pharma (Guilin) Company Information
- 12.5.2 Fosun Pharma (Guilin) Business Overview
- 12.5.3 Fosun Pharma (Guilin) Revenue in Artesunate Medicines Business (2021-2026)
- 12.5.4 Fosun Pharma (Guilin) Artesunate Medicines Product Portfolio
- 12.5.5 Fosun Pharma (Guilin) Recent Developments
- 12.6 Cipla
- 12.6.1 Cipla Company Information
- 12.6.2 Cipla Business Overview
- 12.6.3 Cipla Revenue in Artesunate Medicines Business (2021-2026)
- 12.6.4 Cipla Artesunate Medicines Product Portfolio
- 12.6.5 Cipla Recent Developments
- 12.7 Ajanta Pharma
- 12.7.1 Ajanta Pharma Company Information
- 12.7.2 Ajanta Pharma Business Overview
- 12.7.3 Ajanta Pharma Revenue in Artesunate Medicines Business (2021-2026)
- 12.7.4 Ajanta Pharma Artesunate Medicines Product Portfolio
- 12.7.5 Ajanta Pharma Recent Developments
- 12.8 Acino
- 12.8.1 Acino Company Information
- 12.8.2 Acino Business Overview
- 12.8.3 Acino Revenue in Artesunate Medicines Business (2021-2026)
- 12.8.4 Acino Artesunate Medicines Product Portfolio
- 12.8.5 Acino Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst